Janssen Defends Role As Sole Patent Owner In Remicade Suit
Johnson & Johnson doesn't need to be named as a party in patent infringement litigation regarding subsidiary Janssen Biotech Inc.'s blockbuster biologic Remicade, as Janssen has full patent ownership rights, the...To view the full article, register now.
Already a subscriber? Click here to view full article